首頁 > 市場調查報告書 > 醫療設備

生技設備基因治療學和RNAi

轉錄組學市場規模、佔有率和成長分析：按技術、產品/服務、應用、治療領域、最終用戶和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2036368

轉錄組學市場規模、佔有率和成長分析：按技術、產品/服務、應用、治療領域、最終用戶和地區分類－2026-2033年產業預測

Transcriptomics Market Size, Share, and Growth Analysis, By Technology (Next-Generation Sequencing (RNA-Seq), Microarray), By Product & Service, By Application, By Therapeutic Area, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2026年05月06日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球轉錄組學市場價值為 85 億美元，預計到 2025 年將成長至 2033 年的 235.7 億美元，預測期（2026-2033 年）複合年成長率為 12.0%。

全球轉錄組學市場的主要驅動力是高通量定序和單細胞技術的進步，這些技術已將基因表現分析從專業研究轉向關鍵的臨床應用。該領域涉及對RNA分子進行定量分析，以闡明細胞狀態，並將這些發現應用於診斷、治療標靶和生物標記的研究。從微陣列到批量RNA定序和單細胞RNA定序的演變，其特徵是定序成本顯著降低和生物資訊能力增強。隨著這些技術在腫瘤學、免疫學和感染疾病的應用日益廣泛，對高效診斷和藥物研發的需求也日益成長。關鍵的成長要素包括軟體改進、產學合作、創業投資資金的增加以及有助於商業化和跨學科整合的精簡法規結構。

全球轉錄組學市場促進因素

全球轉錄組學市場主要受定序技術進步和相關試劑開發的影響。這些進步極大地提高了數據品質、處理能力和可近性。這一發展趨勢促使轉錄組學在研究和臨床領域中得到更廣泛的應用。儀器性能的提升和工作流程的簡化降低了技術門檻，使不同專業水平的實驗室更輕鬆地進行複雜的檢測。這些創新為新型檢測方法的開發鋪平了道路，促進了與其他體學學科的整合，並使轉錄組學能夠在診斷和治療領域中得到應用。因此，越來越多的研究人員和臨床醫生在研究和臨床決策流程中使用轉錄組分析，推動了對轉錄組學服務和耗材的需求成長。

全球轉錄組學市場面臨的限制因素

全球轉錄組學市場面臨許多挑戰，包括購買先進設備所需的大量資本投入，以及專用試劑和維護相關的持續成本。這些經濟負擔對小規模實驗室和機構構成障礙，使其難以將常規轉錄組學功能整合到日常運作中。此外，對熟練人員和特定基礎設施的需求也增加了整體實施成本，阻礙了其更廣泛的應用，尤其是在資源匱乏的環境中。因此，市場成長主要局限於資金雄厚的機構，難以擴展到臨床診斷和常規實驗室運作領域。

全球轉錄組學市場趨勢

全球轉錄組學市場正經歷一場變革性趨勢，其特徵是空間分析與單細胞轉錄組學的融合。這項創新透過有效闡明細胞異質性並同時維持組織結構，顯著提升了研究能力。隨著研究人員開發出融合定位和基因表現分析的工作流程，複雜組織內的標靶辨識和生物標記發現正在加速發展。因此，儀器和試劑供應商正在策略性地調整其產品線，以支援先進的數據採集和分析。這種協同作用正在促進合作研究平台和跨學科研究的興起，從而豐富轉化研究，將分子層面的細節與組織學背景聯繫起來，最終有助於治療策略的開發和改進。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Illumina, Inc.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
QIAGEN NV
Bio-Rad Laboratories, Inc.
Danaher Corporation
Oxford Nanopore Technologies plc
Pacific Biosciences of California, Inc.
BGI Genomics Co., Ltd.
PerkinElmer, Inc.
Merck KGaA
Takara Bio Inc.
Standard BioTools Inc.
Revvity, Inc.
Bio-Techne Corporation
Azenta, Inc.
NeoGenomics, Inc.
GenScript Biotech Corporation
Novogene Co., Ltd

結論與建議

簡介目錄

Product Code: UCMIG35J2008

Global Transcriptomics Market size was valued at USD 8.5 Billion in 2024 and is poised to grow from USD 9.52 Billion in 2025 to USD 23.57 Billion by 2033, growing at a CAGR of 12.0% during the forecast period (2026-2033).

The global transcriptomics market is primarily driven by advancements in high-throughput sequencing and single-cell technologies, which have transitioned gene expression analysis from specialized research to vital clinical applications. This field involves quantifying RNA molecules to uncover cellular states, translating these insights into diagnostics, therapeutic targets, and biomarkers. The evolution from microarray-based methods to bulk RNA sequencing and single-cell RNA-seq has been marked by significant reductions in sequencing costs and enhancements in bioinformatics capabilities. As these technologies proliferate within oncology, immunology, and infectious disease sectors, the demand for effective diagnostics and drug development intensifies. Key growth factors include improved software, industry-academia collaborations, increased venture funding, and streamlined regulatory frameworks that foster commercialization and cross-sector integration.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcriptomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcriptomics Market Segments Analysis

Global transcriptomics market is segmented by technology, product & service, application, therapeutic area, end-user and region. Based on technology, the market is segmented into Next-Generation Sequencing (RNA-Seq), Microarray, Polymerase Chain Reaction (qPCR & dPCR), Single-Cell RNA Sequencing (scRNA-seq), Spatial Transcriptomics and In-situ Hybridization (ISH). Based on product & service, the market is segmented into Consumables & Reagents, Instruments, Software & Bioinformatics Tools and Service Providers. Based on application, the market is segmented into Drug Discovery & Development, Clinical Diagnostics & Disease Profiling, Biomarker Identification, Toxicogenomics, Comparative Transcriptomics, Agriculture & Plant Genomics and Others. Based on therapeutic area, the market is segmented into Oncology, Neurology, Immunology & Infectious Diseases, Cardiovascular Diseases and Rare & Genetic Disorders. Based on end-user, the market is segmented into Academic & Government Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical & Diagnostic Laboratories, Hospitals & Medical Centers, Contract Research Organizations (CROs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transcriptomics Market

The Global Transcriptomics market is significantly driven by advancements in sequencing technologies and the development of associated reagents, which have greatly enhanced data quality, throughput, and accessibility. This evolution encourages wider adoption of transcriptomics in both research and clinical environments, as improved instrument performance and streamlined workflows lower technical barriers, making complex assays more user-friendly for laboratories with diverse levels of expertise. These technological innovations pave the way for the creation of novel assays, promote integration with other omics fields, and enable the application of transcriptomics in diagnostic and therapeutic settings. Consequently, there is an increasing demand for transcriptomics services and consumables as more researchers and clinicians utilize transcript profiling in their research and clinical decision-making processes.

Restraints in the Global Transcriptomics Market

The Global Transcriptomics market faces notable challenges due to the substantial capital investment required for advanced instruments, coupled with the continuous costs associated with specialized reagents and maintenance. These financial burdens create obstacles for smaller laboratories and institutions, making it difficult to incorporate routine transcriptomics capabilities into their operations. Furthermore, the necessity for skilled personnel and specific infrastructure adds to the overall implementation costs, which deters broader adoption, particularly in settings with limited resources. As a result, market growth is primarily limited to well-funded institutions, hindering expansion into the clinical diagnostics sector and regular laboratory practices.

Market Trends of the Global Transcriptomics Market

The Global Transcriptomics market is witnessing a transformative trend characterized by the integration of spatial profiling with single-cell transcriptomics. This innovation is enhancing research capabilities by preserving tissue architecture while effectively resolving cellular heterogeneity. As researchers develop workflows that marry localization with gene expression analysis, there is an acceleration in target identification and biomarker discovery within complex tissues. Consequently, instrument and reagent suppliers are strategically aligning their product offerings to support advanced data capture and analysis. This synergy is fostering collaborative platforms and interdisciplinary studies, thereby enriching translational research that connects molecular details to histological contexts, ultimately informing and refining therapeutic strategies.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape
Value Chain Analysis
Case Studies
Technology Assessment
Customer & Buying Criteria Analysis
Pipeline Analysis
Disease Epidemiology

Global Transcriptomics Market Size by Technology & CAGR (2026-2033)

Market Overview
Next-Generation Sequencing (RNA-Seq)
Microarray
Polymerase Chain Reaction (qPCR & dPCR)
Single-Cell RNA Sequencing (scRNA-seq)
Spatial Transcriptomics
In-situ Hybridization (ISH)

Global Transcriptomics Market Size by Product & Service & CAGR (2026-2033)

Market Overview
Consumables & Reagents
Instruments
Software & Bioinformatics Tools
Service Providers

Global Transcriptomics Market Size by Application & CAGR (2026-2033)

Market Overview
Drug Discovery & Development
Clinical Diagnostics & Disease Profiling
Biomarker Identification
Toxicogenomics
Comparative Transcriptomics
Agriculture & Plant Genomics
Others

Global Transcriptomics Market Size by Therapeutic Area & CAGR (2026-2033)

Market Overview
Oncology
Neurology
Immunology & Infectious Diseases
Cardiovascular Diseases
Rare & Genetic Disorders

Global Transcriptomics Market Size by End-User & CAGR (2026-2033)

Market Overview
Academic & Government Research Institutes
Pharmaceutical & Biotechnology Companies
Clinical & Diagnostic Laboratories
Hospitals & Medical Centers
Contract Research Organizations (CROs)
Others

Global Transcriptomics Market Size & CAGR (2026-2033)

North America (Technology, Product & Service, Application, Therapeutic Area, End-User)
- US
- Canada
Europe (Technology, Product & Service, Application, Therapeutic Area, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Product & Service, Application, Therapeutic Area, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Product & Service, Application, Therapeutic Area, End-User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Product & Service, Application, Therapeutic Area, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Azenta, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeoGenomics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novogene Co., Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments